These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2824756)

  • 1. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
    Nakajima M; Adachi I; Ueda M
    Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.
    Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
    Kokubun S; Prod'hom B; Becker C; Porzig H; Reuter H
    Mol Pharmacol; 1986 Dec; 30(6):571-84. PubMed ID: 2431263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
    Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E; Neumann P
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.
    Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):442-51. PubMed ID: 2555723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
    Greenberg DA; Carpenter CL; Messing RO
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta.
    Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P
    J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes.
    Kamp TJ; Sanguinetti MC; Miller RJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.